United States Passive Transdermal Drug Delivery Market Report 2018

March 2018 | 111 pages | ID: UC6BA7031BBEN
QYResearch

Abstracts

In this report, the United States Passive Transdermal Drug Delivery market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Passive Transdermal Drug Delivery in these regions, from 2013 to 2025 (forecast).

United States Passive Transdermal Drug Delivery market competition by top manufacturers/players, with Passive Transdermal Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• 3M
• Actavis, Inc.
• Bayer AG
• Boehringer Ingelheim GmbH
• Corium International, Inc.
• Echo Therapeutics, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson (Janssen Pharmaceuticals Inc.)
• Mylan N.V.
• Novartis AG
• Noven Pharmaceuticals, Inc.
• Transdermal Corp.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Microfluidics
• Smart Pill Technology (SPT)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Passive Transdermal Drug Delivery Market Report 2018

1 PASSIVE TRANSDERMAL DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Passive Transdermal Drug Delivery
1.2 Classification of Passive Transdermal Drug Delivery by Product Category
  1.2.1 United States Passive Transdermal Drug Delivery Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Passive Transdermal Drug Delivery Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Microfluidics
  1.2.4 Smart Pill Technology (SPT)
1.3 United States Passive Transdermal Drug Delivery Market by Application/End Users
  1.3.1 United States Passive Transdermal Drug Delivery Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 United States Passive Transdermal Drug Delivery Market by Region
  1.4.1 United States Passive Transdermal Drug Delivery Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
  1.4.3 Southwest Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
  1.4.5 New England Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
  1.4.6 The South Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
  1.4.7 The Midwest Passive Transdermal Drug Delivery Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Passive Transdermal Drug Delivery (2013-2025)
  1.5.1 United States Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2025)
  1.5.2 United States Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2025)

2 UNITED STATES PASSIVE TRANSDERMAL DRUG DELIVERY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Passive Transdermal Drug Delivery Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Passive Transdermal Drug Delivery Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Passive Transdermal Drug Delivery Average Price by Players/Suppliers (2013-2018)
2.4 United States Passive Transdermal Drug Delivery Market Competitive Situation and Trends
  2.4.1 United States Passive Transdermal Drug Delivery Market Concentration Rate
  2.4.2 United States Passive Transdermal Drug Delivery Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Passive Transdermal Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PASSIVE TRANSDERMAL DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Passive Transdermal Drug Delivery Sales and Market Share by Region (2013-2018)
3.2 United States Passive Transdermal Drug Delivery Revenue and Market Share by Region (2013-2018)
3.3 United States Passive Transdermal Drug Delivery Price by Region (2013-2018)

4 UNITED STATES PASSIVE TRANSDERMAL DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Passive Transdermal Drug Delivery Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Passive Transdermal Drug Delivery Revenue and Market Share by Type (2013-2018)
4.3 United States Passive Transdermal Drug Delivery Price by Type (2013-2018)
4.4 United States Passive Transdermal Drug Delivery Sales Growth Rate by Type (2013-2018)

5 UNITED STATES PASSIVE TRANSDERMAL DRUG DELIVERY SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Passive Transdermal Drug Delivery Sales and Market Share by Application (2013-2018)
5.2 United States Passive Transdermal Drug Delivery Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES PASSIVE TRANSDERMAL DRUG DELIVERY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 3M
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Actavis, Inc.
  6.2.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bayer AG
  6.3.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim GmbH
  6.4.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Corium International, Inc.
  6.5.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Echo Therapeutics, Inc.
  6.6.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline plc
  6.7.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
  6.8.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Mylan N.V.
  6.9.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Novartis AG
  6.10.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Noven Pharmaceuticals, Inc.
6.12 Transdermal Corp.

7 PASSIVE TRANSDERMAL DRUG DELIVERY MANUFACTURING COST ANALYSIS

7.1 Passive Transdermal Drug Delivery Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Passive Transdermal Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Passive Transdermal Drug Delivery Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PASSIVE TRANSDERMAL DRUG DELIVERY MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Passive Transdermal Drug Delivery Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Passive Transdermal Drug Delivery Sales Volume Forecast by Type (2018-2025)
11.3 United States Passive Transdermal Drug Delivery Sales Volume Forecast by Application (2018-2025)
11.4 United States Passive Transdermal Drug Delivery Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Passive Transdermal Drug Delivery
Figure United States Passive Transdermal Drug Delivery Market Size (K Units) by Type (2013-2025)
Figure United States Passive Transdermal Drug Delivery Sales Volume Market Share by Type (Product Category) in 2017
Figure Microfluidics Product Picture
Figure Smart Pill Technology (SPT) Product Picture
Figure United States Passive Transdermal Drug Delivery Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Passive Transdermal Drug Delivery by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Passive Transdermal Drug Delivery Market Size (Million USD) by Region (2013-2025)
Figure The West Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2025)
Figure United States Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Passive Transdermal Drug Delivery Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Passive Transdermal Drug Delivery Sales Share by Players/Suppliers
Figure 2017 United States Passive Transdermal Drug Delivery Sales Share by Players/Suppliers
Figure United States Passive Transdermal Drug Delivery Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Passive Transdermal Drug Delivery Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Passive Transdermal Drug Delivery Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Passive Transdermal Drug Delivery Revenue Share by Players/Suppliers
Figure 2017 United States Passive Transdermal Drug Delivery Revenue Share by Players/Suppliers
Table United States Market Passive Transdermal Drug Delivery Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Passive Transdermal Drug Delivery Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Passive Transdermal Drug Delivery Market Share of Top 3 Players/Suppliers
Figure United States Passive Transdermal Drug Delivery Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Passive Transdermal Drug Delivery Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Passive Transdermal Drug Delivery Product Category
Table United States Passive Transdermal Drug Delivery Sales (K Units) by Region (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales Share by Region (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Share by Region (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Market Share by Region in 2017
Table United States Passive Transdermal Drug Delivery Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Passive Transdermal Drug Delivery Revenue Share by Region (2013-2018)
Figure United States Passive Transdermal Drug Delivery Revenue Market Share by Region (2013-2018)
Figure United States Passive Transdermal Drug Delivery Revenue Market Share by Region in 2017
Table United States Passive Transdermal Drug Delivery Price (USD/Unit) by Region (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales (K Units) by Type (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales Share by Type (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Share by Type (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Market Share by Type in 2017
Table United States Passive Transdermal Drug Delivery Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Passive Transdermal Drug Delivery Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Passive Transdermal Drug Delivery by Type (2013-2018)
Figure Revenue Market Share of Passive Transdermal Drug Delivery by Type in 2017
Table United States Passive Transdermal Drug Delivery Price (USD/Unit) by Types (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Growth Rate by Type (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales (K Units) by Application (2013-2018)
Table United States Passive Transdermal Drug Delivery Sales Market Share by Application (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Market Share by Application (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Market Share by Application in 2017
Table United States Passive Transdermal Drug Delivery Sales Growth Rate by Application (2013-2018)
Figure United States Passive Transdermal Drug Delivery Sales Growth Rate by Application (2013-2018)
Table 3M Basic Information List
Table 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Sales Market Share in United States (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Revenue Market Share in United States (2013-2018)
Table Actavis, Inc. Basic Information List
Table Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Sales Market Share in United States (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Revenue Market Share in United States (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Sales Market Share in United States (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Revenue Market Share in United States (2013-2018)
Table Corium International, Inc. Basic Information List
Table Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Sales Market Share in United States (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Revenue Market Share in United States (2013-2018)
Table Echo Therapeutics, Inc. Basic Information List
Table Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales Market Share in United States (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information List
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Revenue Market Share in United States (2013-2018)
Table Mylan N.V. Basic Information List
Table Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Sales Market Share in United States (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Revenue Market Share in United States (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Sales Growth Rate (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Sales Market Share in United States (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Revenue Market Share in United States (2013-2018)
Table Noven Pharmaceuticals, Inc. Basic Information List
Table Transdermal Corp. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Passive Transdermal Drug Delivery
Figure Manufacturing Process Analysis of Passive Transdermal Drug Delivery
Figure Passive Transdermal Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Passive Transdermal Drug Delivery Major Players/Suppliers in 2017
Table Major Buyers of Passive Transdermal Drug Delivery
Table Distributors/Traders List
Figure United States Passive Transdermal Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Passive Transdermal Drug Delivery Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Passive Transdermal Drug Delivery Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Passive Transdermal Drug Delivery Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Passive Transdermal Drug Delivery Sales Volume (K Units) Forecast by Type in 2025
Table United States Passive Transdermal Drug Delivery Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Passive Transdermal Drug Delivery Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Passive Transdermal Drug Delivery Sales Volume (K Units) Forecast by Application in 2025
Table United States Passive Transdermal Drug Delivery Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Passive Transdermal Drug Delivery Sales Volume Share Forecast by Region (2018-2025)
Figure United States Passive Transdermal Drug Delivery Sales Volume Share Forecast by Region (2018-2025)
Figure United States Passive Transdermal Drug Delivery Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources